Cocaine abuse among methadone maintenance patients: are there effective treatment strategies?

Journal of Psychoactive Drugs
R A RawsonW Ling

Abstract

Cocaine abuse among patients in methadone maintenance treatment has substantially increased in the past decade. No standard treatment approaches exist to address this problem. Empirical evidence has been collected on the effectiveness of several categories of techniques for treating this problem, including pharmacotherapies, behavioral methods (contingency management and relapse prevention), and methadone dose adjustment. Data on the effectiveness of these techniques is summarized. In addition, other treatment interventions that may be efficacious for this population, including day treatment and sober-living facilities, are described. Finally, methadone clinic management procedures that may aid in the reduction of cocaine abuse by methadone patients are discussed. Although many of these efforts are in early stages of evaluation, there are some reasons for optimism in the development of treatment for these patients.

References

Feb 1, 1992·Lancet·S Bewley, T H Bewley
Nov 1, 1992·Archives of General Psychiatry·T R KostenR S Schottenfeld
Nov 1, 1992·Archives of General Psychiatry·R E Meyer
Jun 1, 1992·Journal of Clinical Psychopharmacology·S M Stine, T R Kosten
Oct 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·C J Ball
Jan 1, 1991·Journal of Addictive Diseases·S MaguraD S Lipton
Jan 1, 1991·Journal of Substance Abuse Treatment·W S CondelliJ V Rachal
Sep 1, 1991·The American Journal of Psychiatry·S T HigginsJ W Fenwick
Sep 1, 1991·The American Journal of Drug and Alcohol Abuse·K M CarrollF H Gawin
Apr 1, 1990·Journal of Psychoactive Drugs·R A RawsonW Ling
Jan 1, 1990·Journal of Substance Abuse Treatment·D A CalsynS Lee-Meyer
Feb 1, 1989·Archives of General Psychiatry·F H GawinC Morgan
Jan 1, 1989·Psychopharmacology·J Gross, M L Stitzer
Jul 1, 1989·Diagnostic Microbiology and Infectious Disease·H Washton
Jan 1, 1989·Journal of Substance Abuse Treatment·B C Wallace
Sep 1, 1989·Canadian Journal of Physiology and Pharmacology·M A Bozarth
May 18, 1985·Lancet·C A Dackis, M S Gold
Jan 27, 1989·JAMA : the Journal of the American Medical Association·R E ChaissonA R Moss
Apr 1, 1989·Archives of General Psychiatry·F H GawinB Humblestone
Jan 1, 1988·Life Sciences·T R Kosten, H D Kleber
Jan 1, 1988·Addictive Behaviors·S MaguraD S Lipton
Apr 1, 1987·Journal of Clinical Pharmacology·A J GianniniL R DiMarzio
Jan 1, 1987·Archives of Internal Medicine·F S Tennant, A A Sagherian
Jan 1, 1987·Addictive Behaviors·J L BlackH A DeFord
Jan 1, 1986·The American Journal of Drug and Alcohol Abuse·T R KostenH D Kleber
Mar 1, 1987·Archives of General Psychiatry·T R KostenH D Kleber
Feb 1, 1973·Behaviour Research and Therapy·G M Hunt, N H Azrin
Jan 1, 1972·The International Journal of the Addictions·C D ChambersA D Moffett
Jan 1, 1982·Journal of Applied Behavior Analysis·M L StitzerJ W Hawthorne
Sep 1, 1984·Archives of General Psychiatry·F H Gawin, H D Kleber
Mar 1, 1995·Journal of Substance Abuse Treatment·R A RawsonW Ling
Jan 1, 1993·Journal of Substance Abuse Treatment·C G Leukefeld, F R Tims
May 1, 1993·The American Journal of Psychiatry·S T HigginsG Badger
Jun 1, 1993·The Journal of Nervous and Mental Disease·T R KostenJ Falcioni
Sep 15, 1998·Journal of Consulting and Clinical Psychology·K L PrestonE J Cone

❮ Previous
Next ❯

Citations

Jun 8, 2002·Sozial- Und Präventivmedizin·Richard BlättlerAmbros Uchtenhagen
May 1, 1995·Journal of Substance Abuse Treatment·S K AvantsS Birch
Nov 1, 1996·Journal of Substance Abuse Treatment·A RosenblumB Stimmel
Jan 1, 1997·Journal of Substance Abuse Treatment·S M DeesD D Simpson
Jul 1, 1997·Journal of Substance Abuse Treatment·N R FinemanM Espinosa
Jun 20, 1998·Journal of Substance Abuse Treatment·R Heimer
Aug 6, 2000·The International Journal on Drug Policy·N SeivewrightT Millar
Apr 16, 2002·Journal of Consulting and Clinical Psychology·Nancy M Petry, Bonnie Martin
Oct 16, 2004·Journal of Consulting and Clinical Psychology·Kenneth SilvermanMaxine L Stitzer
Jun 13, 1998·Journal of Psychoactive Drugs·W A Zule, D P Desmond
Aug 7, 1999·Journal of Psychoactive Drugs·S Maxwell, M Shinderman
May 27, 2005·Journal of Psychoactive Drugs·Grace A Rowan-SzalD Dwayne Simpson
Oct 22, 1998·Substance Use & Misuse·S MaguraS Demsky
Nov 21, 1997·The American Journal of Drug and Alcohol Abuse·W A ZuleK N Vogtsberger
Feb 6, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Marya SchulteYih-Ing Hser
Mar 21, 2000·American Journal of Health Promotion : AJHP·M Gutman, R Clayton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
L L Cregler, H Mark
The American Journal of Drug and Alcohol Abuse
J A HalikasR Crosby
© 2021 Meta ULC. All rights reserved